These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16096716)

  • 41. Combination therapy with antiangiogenic treatment and photodynamic therapy for the nude mouse bearing U87 glioblastoma.
    Jiang F; Zhang X; Kalkanis SN; Zhang Z; Yang H; Katakowski M; Hong X; Zheng X; Zhu Z; Chopp M
    Photochem Photobiol; 2008; 84(1):128-37. PubMed ID: 18173712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive factor for photodynamic therapy effects on oral squamous cell carcinoma and oral epithelial dysplasia.
    Uehara M; Ikeda H; Nonaka M; Sumita Y; Nanashima A; Nonaka T; Asahina I
    Arch Oral Biol; 2011 Nov; 56(11):1366-72. PubMed ID: 21596370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
    Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
    J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model.
    Li LB; Luo RC
    Lasers Med Sci; 2009 Jul; 24(4):597-603. PubMed ID: 18936869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.
    Ferrario A; Rucker N; Wong S; Luna M; Gomer CJ
    Cancer Res; 2007 May; 67(10):4989-95. PubMed ID: 17510430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
    Lilge L; Wilson BC
    J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expression of angiogenic factors by photodynamic therapy].
    Rudolf M; Michels S; Schlötzer-Schrehardt U; Schmidt-Erfurth U
    Klin Monbl Augenheilkd; 2004 Dec; 221(12):1026-32. PubMed ID: 15599809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
    Nakagawa H; Matsumiya T; Sakaki H; Imaizumi T; Kubota K; Kusumi A; Kobayashi W; Kimura H
    Oral Oncol; 2007 Jul; 43(6):544-50. PubMed ID: 17257889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Photodynamic therapy of human glioma (U87) in the nude rat.
    Chopp M; Madigan L; Dereski M; Jiang F; Li Y
    Photochem Photobiol; 1996 Oct; 64(4):707-11. PubMed ID: 8863478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination with genistein enhances the efficacy of photodynamic therapy against human anaplastic thyroid cancer cells.
    Ahn JC; Biswas R; Chung PS
    Lasers Surg Med; 2012 Dec; 44(10):840-9. PubMed ID: 23143780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model.
    Matsubara A; Nakazawa T; Husain D; Iliaki E; Connolly E; Michaud NA; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2498-507. PubMed ID: 16723462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroprotective response after photodynamic therapy: role of vascular endothelial growth factor.
    Suzuki M; Ozawa Y; Kubota S; Hirasawa M; Miyake S; Noda K; Tsubota K; Kadonosono K; Ishida S
    J Neuroinflammation; 2011 Dec; 8():176. PubMed ID: 22171708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental research photodynamic effects in perifocal, oedematous brain tissue.
    Goetz C; Hasan A; Stummer W; Heimann A; Kempski O
    Acta Neurochir (Wien); 2002 Feb; 144(2):173-9; discussion 179. PubMed ID: 11862518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Photodynamic therapy and anti-tumor immunity.
    Gollnick SO; Owczarczak B; Maier P
    Lasers Surg Med; 2006 Jun; 38(5):509-15. PubMed ID: 16788921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro photodynamic therapy on human U251 glioma cells with a novel photosensitiser ZnPcS4-BSA.
    Xu D; Ke Y; Jiang X; Cai Y; Peng Y; Li Y
    Br J Neurosurg; 2010 Dec; 24(6):660-5. PubMed ID: 20707684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
    Chan WS; Brasseur N; La Madeleine C; van Lier JE
    Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of 5-ALA-PDT on VEGF and PCNA expression in human NPC-bearing nude mice.
    Xie Y; Wei ZB; Zhang Z; Wen W; Huang GW
    Oncol Rep; 2009 Dec; 22(6):1365-71. PubMed ID: 19885588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of mitochondria in cell death induced by Photofrin-PDT and ursodeoxycholic acid by means of SLIM.
    Kinzler I; Haseroth E; Hauser C; Rück A
    Photochem Photobiol Sci; 2007 Dec; 6(12):1332-40. PubMed ID: 18046490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced susceptibility of mouse squamous cell carcinoma to photodynamic therapy combined with low-dose administration of cisplatin.
    Uehara M; Inokuchi T; Ikeda H
    J Oral Maxillofac Surg; 2006 Mar; 64(3):390-6. PubMed ID: 16487799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.